Chartsbank is a comprehensive database containing information on more than 3000 new drugs in development, inclusive of pre-clinical research up to phase IV development

Subscribers view details.


 
Please Select Filter Criteria for the drug pipeline
Drug Pipeline by drug name:
Drug Pipeline by Company:
Drug Pipeline by Disease:

Subscribe

Drug Pipeline by Generic :
Drug Pipeline by Current Status:
Drug Pipeline by ICN:

12345678910...
CompanyDrug NameStatusIndication Group
Millennium Velcade and prednisone in Phase IIIAntineoplastic & immunomodulating agents
Millennium Velcade Approved in USAAntineoplastic & immunomodulating agents
Millennium Velcade discontinuedAntineoplastic & immunomodulating agents
Millennium Velcade in Phase IIAntineoplastic & immunomodulating agents
Millennium Velcade Approved in EU and USAAntineoplastic & immunomodulating agents
VasGene Therapeutics Veglin and IL-2 accomplished Phase IAntineoplastic & immunomodulating agents
VasGene Therapeutics Veglin and Gemsar accomplished Phase IAntineoplastic & immunomodulating agents
VasGene Therapeutics Veglin and Alimta/Cisplatinum accomplished Phase IAntineoplastic & immunomodulating agents
VasGene Therapeutics Veglin accomplished Phase IAntineoplastic & immunomodulating agents
Amgen Vectibix Approved in USAAntineoplastic & immunomodulating agents
Coley Pharmaceutical Group Vaximmune in Phase IIIAntineoplastic & immunomodulating agents
Astellas Pharma Vaprisol Approved in USAAlimentary tract & metabolism
Valera Vantas Approved in USANervous system
King Vanquix in Phase IIIAntineoplastic & immunomodulating agents
Medicis Vanos Approved in USADermatologicals
Bristol-Myers Squibb Vanlev HCTZ Submitted for approval in USACardiovascular system
Bristol-Myers Squibb Vanlev in Phase IIIAlimentary tract & metabolism
BioPartners Valtropin Approved in EUSystemic hormonal preparations
GlaxoSmithKline Valtrex/Zelitrex Approved in USAAnti-infectives for systemic use
GlaxoSmithKline Valtrex XR in Phase IAnti-infectives for systemic use
12345678910...




Drug Pipeline Copyright © 2005- 2017 All Rights Reserved.